SKIMS Sets Up Pharmacovigilance Committees to Enhance Drug Safety Monitoring

An official order stated, "In partial modification to office order under refernce, sanction is hereby accorded to the reconstitution of Pharmacoviqilance Committee at SKIMS, Comprising the following, for detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem, as per the guidelines of National Medical Commission (NMC) and National Board of Examinations in Medical Sciences (NBEMS)". 

The primary objectives include continuous monitoring of the benefit-risk profile of medicines administered within SKIMS institutions. Additionally, the committees will generate independent, evidence-based safety recommendations and communicate their findings with relevant stakeholders to ensure transparency and accountability. Other key responsibilities include promoting research initiatives focused on pharmacovigilance, initiating measures to reduce the occurrence of ADRs, and making drug therapies safer and more rational. The establishment of these committees underlines SKIMS’s commitment to strengthening patient safety protocols and contributing actively to national healthcare quality standards.

The Pharmacovigilance Committee members at SKIMS Soura are- Prof. Faroog Ahmad Jan, Medical Superintendent, SKIMS, Soura, Prof. Bashir Ahmad Fomda, Head, Department of Microbiology & I/C Head, Department of Clinical Pharmacology, Prof. Mushtaq Ahmad Bhat, Head, Department of Pediatric & Neonatology, Prof. Sheikh Riaz Rasool, Department of Radio-diagnosis, Prof. Bashir Ahmad Dar, Department of Anesthesiology, Prof. Ajaz Nabi Koul, Department of General Medicine, Prof. Rabia Khurshid, Department of Obstetrics & Gynecology, Dr. Munir Ahmad Wani, Additional Professor, Department of General Surgery, Officer I/C Drug & Pharmacy and Officer I/C Nursing Administration.